Latest Media Releases (Page 14) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Chimeric Therapeutics secures up to A$12.6m through SPP and placements (ASX:CHM)

Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), the only ASX-listed clinical stage cell therapy company, announces the successful completion of its Securities P...read more

Immutep granted US patent for IMP761 agonist LAG-3 antibody (ASX:IMM)

SYDNEY, AUSTRALIA – 20 June 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapiesfor cancer and autoimmune disea...read more

Next Science - Appointment of new Managing Director and CEO (ASX:NXS)

Sydney Australia Friday, 16 June 2023: Next Science Limited (ASX: NXS) (Next Science or Company), a medical technology company focused on commercialising its proprietary XBIOTM suite of products to ...read more

Austco awarded $7.4m contract, largest in its history (ASX:AHC)

Largest contract win in Austco Healthcare's history. Agreement to supply advanced Tacera alarm management and clinical workflow solution. Construction has commenced...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the announcement, download the attached PDF.

Viewing: 196 - 210 of 200 Previous | Next